Shanti Pal Gangwar

Shanti Pal Gangwar

Auto-generated profile, based on publicly available information

Shanti Pal Gangwar

Department of Biochemistry and Molecular Biophysics, Columbia University, New York, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Neuron
Verified
Journal Article
Closed access
SGShanti Pal Gangwar
Shanti Pal Gangwar
XZXiaoying Zhong
Xiaoying Zhong
SSSuchithra Seshadrinathan
Suchithra Seshadrinathan
HCHui Chen
Hui Chen
MMMischa Machius
Mischa Machius
GRGabby Rudenko
Gabby Rudenko

14 October 2021 in Molecular Cell
Verified
Journal Article
Closed access
OKOleg Klykov
Oleg Klykov
SGShanti Pal Gangwar
Shanti Pal Gangwar
MYMaria V. Yelshanskaya
Maria V. Yelshanskaya
LYLaura Yen
Laura Yen
ASAlexander I. Sobolevsky
Alexander I. Sobolevsky

26 July 2016 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
MKM J Kim
M J Kim
JBJ Biag
J Biag
DFD M Fass
D M Fass
MLM C Lewis
M C Lewis
QZQ Zhang
Q Zhang
SHS J Haggarty
S J Haggarty

2 February 2021 in Structure
Verified
Journal Article
Closed access
SFShanghua Fan
Shanghua Fan
SGShanti Pal Gangwar
Shanti Pal Gangwar
MMMischa Machius
Mischa Machius
GRGabby Rudenko
Gabby Rudenko

31 August 2023 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
SGShanti Pal Gangwar
Shanti Pal Gangwar
LYLaura Y. Yen
Laura Y. Yen
MYMaria V. Yelshanskaya
Maria V. Yelshanskaya
AKAryeh Korman
Aryeh Korman
DJDrew R. Jones
Drew R. Jones
ASAlexander I. Sobolevsky
Alexander I. Sobolevsky
Synaptic complexes of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs) with auxiliary subunits mediate most excitatory neurotransmission and can be targeted to treat neuropsychiatric and neurological disorders, including epilepsy. Here we present cryogenic-electron microscopy structures of rat GluA2 AMPAR complexes with inhibitory mouse γ5 and potentiating human cornichon-2 (CNIH2) auxiliary subunits. CNIH2 appears to destabilize the desensitized state of the complex by reducing the separation of the upper lobes in ligand-binding domain dimers. At the same time, CNIH2 stabilizes binding of polyamine spermidine to the selectivity filter of the closed ion channel. Nevertheless, CNIH2, and to a lesser extent γ5, attenuate polyamine block of the open channel and reduce the potency of the antiepileptic drug perampanel that inhibits the synaptic complex allosterically by binding to sites in the ion channel extracellular collar. These findings illustrate the fine-tuning of synaptic complex structure and function in an auxiliary subunit-dependent manner, which is critical for the study of brain region-specific neurotransmission and design of therapeutics for disease treatment.

22 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
SGShanti Pal Gangwar
Shanti Pal Gangwar
MYMaria V. Yelshanskaya
Maria V. Yelshanskaya
KNKirill Nadezhdin
Kirill Nadezhdin
LYLaura Y. Yen
Laura Y. Yen
TNThomas P. Newton
Thomas P. Newton
ASAlexander I. Sobolevsky
Alexander I. Sobolevsky
Kainate receptors, a subclass of ionotropic glutamate receptors, are tetrameric ligand-gated ion channels that mediate excitatory neurotransmission1–4. Kainate receptors modulate neuronal circuits and synaptic plasticity during the development and function of the central nervous system and are implicated in various neurological and psychiatric diseases, including epilepsy, depression, schizophrenia, anxiety and autism5–11. Although structures of kainate receptor domains and subunit assemblies are available12–18, the mechanism of kainate receptor gating remains poorly understood. Here we present cryo-electron microscopy structures of the kainate receptor GluK2 in the presence of the agonist glutamate and the positive allosteric modulators lectin concanavalin A and BPAM344. Concanavalin A and BPAM344 inhibit kainate receptor desensitization and prolong activation by acting as a spacer between the amino-terminal and ligand-binding domains and a stabilizer of the ligand-binding domain dimer interface, respectively. Channel opening involves the kinking of all four pore-forming M3 helices. Our structures reveal the molecular basis of kainate receptor gating, which could guide the development of drugs for treatment of neurological disorders.